Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2023-04-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
监事会关于公司内部控制自我评价报告的核查意见
Regulatory Filings Classification · 95% confidence The document is a supervisory board's opinion on the company's internal control self-evaluation report for the year 2022. It references relevant laws and regulations and states that the supervisory board has reviewed the internal control self-evaluation report and provides their opinion. The document is short (476 characters) and serves as an announcement of the supervisory board's review and opinion rather than the full report itself. It does not contain detailed financial data or the full internal control report. Therefore, it fits best as a Regulatory Filing (RNS), which covers compliance documents and miscellaneous filings that do not fit other categories.
2023-04-26 Chinese
2022年年度报告
Annual Report Classification · 100% confidence The document is titled as the "2022 年年度报告全文" which translates to "2022 Annual Report Full Text" for 康泰医学系统（秦皇岛）股份有限公司. It contains detailed sections including company overview, financial data, management discussion and analysis, corporate governance, environmental and social responsibility, shareholding information, bond information, and a full financial report section. The document includes signatures from the legal representative, accounting heads, and auditors, indicating it is a complete and official annual report. The length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K). FY 2022
2023-04-26 Chinese
独立董事关于第三届董事会第二十七次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion report related to the 27th meeting of the third board of directors of 康泰医学系统（秦皇岛）股份有限公司. It covers various governance and compliance matters such as reappointment of auditors, internal control evaluation, profit distribution proposals, remuneration, board member elections, financial derivative business, changes in convertible bond fund usage, and accounting policy changes. The content is focused on board and management decisions and opinions rather than financial results or audit reports. It does not contain financial statements or earnings data, nor is it a simple announcement or certification. The document aligns with the category of Board/Management Information (MANG), which includes announcements of changes or opinions related to the company's board and senior management activities.
2023-04-26 Chinese
《公司章程》
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of 康泰医学系统（秦皇岛）股份有限公司, which is a detailed corporate governance document outlining the company's organizational structure, shareholder rights, board responsibilities, and other internal rules. It includes chapters on general provisions, business scope, shares, shareholders and shareholders' meetings, board of directors, senior management, supervisory board, financial accounting system, profit distribution, audit, notices and announcements, mergers, amendments to the articles, and supplementary provisions. The content is legal and governance-focused, not a financial report, earnings release, or announcement of voting results. It is a governance document detailing the company's internal rules and governance practices. Therefore, the appropriate classification is Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the articles, not a brief announcement or summary.
2023-04-26 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting policies by 康泰医学系统（秦皇岛）股份有限公司. It details the reasons for the change, references specific accounting standards issued by the Ministry of Finance, and includes opinions from the board of directors, supervisory board, and independent directors. The document does not contain financial statements or detailed financial data but is a formal disclosure of a policy change. It is relatively short (1826 characters) and serves as an official announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories.
2023-04-26 Chinese
中信建投证券股份有限公司关于康泰医学系统（秦皇岛）股份有限公司变更可转债募集资金用途的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed report from CITIC Securities regarding the change in the use of proceeds from a convertible bond issuance by Kangtai Medical System (Qinhuangdao) Co., Ltd. It includes extensive information about the original and revised investment projects, financial figures related to the bond issuance, approvals from the board, supervisory board, and independent directors, as well as the sponsor's verification opinion. The document is focused on the use of funds raised through convertible bonds, which is a capital raising activity. It is not a full annual or interim financial report, nor is it a simple announcement or certification. The content aligns with updates on company fundraising and capital structure changes, fitting the definition of a Capital/Financing Update (CAP). The document length (9109 characters) and detailed content confirm it is a substantive report, not just an announcement or regulatory filing.
2023-04-26 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.